Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
Mara Meyer EpsteinDevi SundaresanMeagan FairHassan FouayziErica T WarnerLawrence D GarberJerry H GurwitzTerry S FieldPublished in: Cancer causes & control : CCC (2022)
The observed decline in two common screening procedures during the COVID-19 pandemic reflects the impact of the pandemic on cancer early detection and signals potential downstream effects on the prognosis of delayed cancer diagnoses. The slower rate of return for breast cancer screening procedures in certain subgroups should be investigated to ensure all women return for routine screenings.
Keyphrases
- prostate cancer
- papillary thyroid
- squamous cell
- sars cov
- coronavirus disease
- radical prostatectomy
- polycystic ovary syndrome
- childhood cancer
- lymph node metastasis
- type diabetes
- clinical practice
- adipose tissue
- pregnant women
- metabolic syndrome
- atomic force microscopy
- skeletal muscle
- human health
- mass spectrometry
- high resolution
- breast cancer risk
- pregnancy outcomes
- high speed